Neumora Therapeutics Stock Forecast

Sell candidate since Jun 12, 2026 Loss -15.17%

The Neumora Therapeutics, Inc. stock price gained 3.42% on the last trading day (Thursday, 25th Jun 2026), rising from $1.46 to $1.51. During the last trading day the stock fluctuated 9.29% from a day low at $1.40 to a day high of $1.53. The price has risen in 5 of the last 10 days but is still down by -5.63% for this period. Volume fell on the last day by -1 million shares and in total, 924 thousand shares were bought and sold for approximately $1.40 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.58 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -33.02% during the next 3 months and, with a 90% probability hold a price between $0.553 and $1.06 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NMRA Signals & Forecast

There are few to no technical positive signals at the moment. The Neumora Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.53 and $1.73. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 23, 2026, and so far it has fallen -6.21%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Neumora Therapeutics, Inc. stock

Neumora Therapeutics, Inc. finds support from accumulated volume at $1.46 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.130 between high and low, or 9.29%. For the last week the stock has had daily average volatility of 11.86%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NMRA) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Neumora Therapeutics, Inc. to open at $1.48, and during the day (based on 14 day Average True Range), to move between $1.40 and $1.62, which gives a possible trading interval of +/-$0.210 (+/-14.95%) up or down from last closing price. If Neumora Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 14.95% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.53 (1.32%) than the support at $1.46 (3.31%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Neumora Therapeutics, Inc. stock A Buy?

Neumora Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.781 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 26, 2026 - $1.48 ( 1.99%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk